Genetically Modified Lactic Acid Bacteria in the EU Food Chain: Applications, Benefits, and Risk Assessment
International Journal of Molecular Sciences · 23.04.2026 · 27 (9) · 3759
DOI: 10.3390/ijms27093759 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.04.2026. Verfasst von Mirco Vacca und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Soil, Plant and Food Sciences (Di.S.S.P.A.), University of Bari Aldo Moro, Via G. Amendola 165A, 70126 Bari, Italy. Hauptthemen laut MEDLINE: Lactobacillales, Microorganisms, Genetically-Modified, Food Microbiology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 262 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Recovery and Resilience Plan, Italian Ministry of University and Research.
Abstract (Originalsprache)
Genetically modified (GM) lactic acid bacteria (LAB) are gaining attention as tools for innovation in the food sector, health applications, and industrial processes. LAB have long been used safely due to their GRAS/QPS status, making them suitable for improving fermentation and synthesizing specific and beneficial metabolites. Advances in genomics and gene editing have significantly expanded the available tools, ranging from classical mutagenesis to site-specific recombination, homologous recombination in non-coding regions, CRISPR-based systems, and food-grade chromosomal integration. These approaches enable the insertion of desired genes and the development of engineered strains with tailored functionalities. GM-LAB are also being studied as live delivery systems for therapeutic molecules, including cytokines, hormones, antimicrobial peptides, and vaccine antigens. Engineered strains of Lactococcus lactis and Lactobacillus spp. have yielded promising outcomes in applications such as mucosal immunization, modulation of inflammatory and metabolic responses, and inhibition of pathogenic microorganisms, including multidrug-resistant bacteria. From an industrial perspective, several studies highlight their potential for cost-effective recombinant protein production and the synthesis of high-value metabolites through fermentation. However, within the European Union, their use is subject to stringent regulatory oversight, requiring comprehensive molecular and environmental risk assessments, careful evaluation of horizontal gene transfer, and a preference for markerless chromosomal integrations. Despite these constraints, GM-LAB offer significant potential to improve food quality, sustainability, and human health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Soil, Plant and Food Sciences (Di.S.S.P.A.), University of Bari Aldo Moro, Via G. Amendola 165A, 70126 Bari, Italy.
ORCID-Profile: Mirco Vacca, Francesco Maria Calabrese, Pasquale Filannino, Maria De Angelis
Förderung
- National Recovery and Resilience Plan
- Italian Ministry of University and Research
Zitieren
APA
Vacca, M., Calabrese, F. M., Filannino, P., & De Angelis, M. (2026). Genetically Modified Lactic Acid Bacteria in the EU Food Chain: Applications, Benefits, and Risk Assessment. International Journal of Molecular Sciences, 27(9), 3759. https://doi.org/10.3390/ijms27093759
Vancouver
Vacca M, Calabrese FM, Filannino P, De Angelis M. Genetically Modified Lactic Acid Bacteria in the EU Food Chain: Applications, Benefits, and Risk Assessment. International Journal of Molecular Sciences. 2026;27(9):3759. doi:10.3390/ijms27093759
BibTeX
@article{Vacca2026,
author = {Vacca, Mirco and Calabrese, Francesco Maria and Filannino, Pasquale and De Angelis, Maria},
title = {Genetically Modified Lactic Acid Bacteria in the EU Food Chain: Applications, Benefits, and Risk Assessment},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {9},
pages = {3759},
doi = {10.3390/ijms27093759}
}
EUVIMED